Brian T Ethell Selected Research

NU-ICRF 505

5/2006	Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.
2/2002	Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian T Ethell Research Topics

Disease

3	Colonic Neoplasms (Colon Cancer) 05/2006 - 02/2002
2	Colorectal Neoplasms (Colorectal Cancer) 05/2006 - 02/2002
1	Hypotension (Low Blood Pressure) 08/2015
1	Bradycardia 08/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2015
1	Overactive Urinary Bladder (Overactive Bladder) 10/2014
1	Neoplasms (Cancer) 12/2003

Drug/Important Bio-Agent (IBA)

2	NU-ICRF 505IBA 05/2006 - 02/2002
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2006 - 02/2002
2	Topoisomerase I InhibitorsIBA 12/2003 - 02/2002
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 08/2015
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2015
1	Tiotropium Bromide (Spiriva)FDA Link 08/2015
1	Bronchodilator Agents (Bronchodilators)IBA 08/2015
1	Muscarinic AntagonistsIBA 08/2015
1	IceIBA 10/2014
1	IsoenzymesIBA 12/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2003
1	Uridine Diphosphate (UDP)IBA 12/2003
1	Food Additives (Food Additive)IBA 12/2003
1	Pharmaceutical PreparationsIBA 12/2003
1	Proteins (Proteins, Gene)FDA Link 12/2003
1	trioctyl phosphine oxide (TOPO)IBA 02/2002
1	Tyrosine (L-Tyrosine)FDA Link 02/2002
1	AnthraquinonesIBA 02/2002
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 05/2006 - 12/2003
1	Therapeutics 08/2015